International Publisher of Science, Technology and Medicine


Mark Kindy

Mark Kindy

Mark Kindy, PHD
Department of Pharmaceutical Sciences in the College of Pharmacy
University of South Florida, USA



Dr. Mark Kindy is a biochemist/neuroscientist and Professor/Associate Dean for Research in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of South Florida and Senior Research Career Scientist at the James A. Haley VA Medical Center. He recently moved from the Department of Regenerative Medicine and Cell Biology and Neurosciences at the Medical University of South Carolina and a Senior Research Career Scientist/Deputy Associate Chief of Staff for Research at the Ralph H. Johnson VA Medical Center in Charleston, SC. He received his BS from the University of Massachusetts in Zoology and PhD from Boston University School of Medicine in Biochemistry. He was a postdoctoral fellow at the Salk Institute. Dr. Kindy started his faculty career at the University of Kentucky School of Medicine in the Department of Biochemistry and the Center on Aging. His area of expertise is neurodegenerative disorders, animal modeling, mechanisms associated with diseases and regeneration of the brain.

Research Interest

Dr. Mark S. Kindy's research focus is on the developing and aging nervous system of humans and marine mammals. Specific emphasis is directed towards neuroinflammatory diseases. Recent work has begun to examine the role of environmental toxins on the nervous system in the mouse models. Dissection of the signaling pathways that lead to apoptotic and non-caspase mediated cell death are the important aspects of this work and may lead to the development of therapeutic agents. Other areas of our work are focused on understanding the neurotoxic effects of marine biotoxins originating from dinoflagellates. Both in vitro and in vivo models are used to study the effects of these toxins in the nervous system. Additionally, his aim is to address human health problems through chemical and biological research on compounds derived from marine organisms. Using cell culture and mouse models of human diseases, he is screening chemical components derived from these organisms to identify potential new therapeutic agents for treating human diseases, such as stroke and Alzheimer’s disease."


Brain Lesions: To Biopsy or Not To Biopsy. A Single Institution Experience
Research Article:  J Neurosci Clin Res 2016, 1:1
doi: 10.4172/jnscr.1000101
Gabriel MA, John LA, Christie LM, Albert FJ, Ruby ABG
Abstract  |   Full-text  |   PDF  |  
Reduction in Forebrain Parenchymal and Cortical Grey Matter Swelling across Treatment Groups in Patients with Inflammatory Illness Acquired Following Exposure to Water-Damaged Buildings
Research Article:  J Neurosci Clin Res 2016, 1:1
doi: 10.4172/jnscr.1000102
McMahon SW, Shoemaker RC and Ryan JC
Abstract  |   Full-text  |   PDF  |  
Predictors of Outcome in Patients with Severe Traumatic Brain Injury
Research Article:  J Neurosci Clin Res 2016, 1:1
doi: 10.4172/jnscr.1000103
Leonidas Grigorakos, Anastasia Alexopoulou, Katerina Tzortzopoulou, Stamatοula Stratouli, Despoina Chroni, Eleni Papadaki, Ioannis Alamanos and Nikolaos Sakellaridis
Abstract  |   Full-text  |   PDF  |  
Using Eye-Tracking as Support for the TEACCH Program and Two Teenagers with Autism-Spectrum Disorders..
Case Report:   J Neurosci Clin Res 2016, 1:1
doi: 10.4172/jnscr.1000104
Fabienne Giuliani
Abstract  |   Full-text  |   PDF  |  
The Effect Of Anti-Epileptic Drugs On Visual Evoked Potential In Patients With Generalized Tonic-Clonic Seizures: A Prospective Case-Controlled Study
Research Article:  J Neurosci Clin Res 2016, 1:1
doi: 10.4172/jnscr.1000105
Alshareef Aysha and Dandachi Nadia
Abstract  |   Full-text  |   PDF  |  
izmit escort sex geschichten escort bayan porno sikis adult porno pornolar
anakara escort